Failure to thrive potentially secondary to maternal venlafaxine use

Australas Psychiatry. 2016 Feb;24(1):98-9. doi: 10.1177/1039856215618528.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antidepressive Agents, Second-Generation / administration & dosage
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Anxiety / drug therapy
  • Body Weight
  • Breast Feeding
  • Depression / drug therapy
  • Failure to Thrive / etiology*
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Venlafaxine Hydrochloride / administration & dosage
  • Venlafaxine Hydrochloride / adverse effects*

Substances

  • Antidepressive Agents, Second-Generation
  • Venlafaxine Hydrochloride